Published in Radiat Prot Dosimetry on December 06, 2006
Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol (1992) 2.08
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst (2001) 1.82
Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol (1999) 1.70
Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol (1998) 1.60
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant (1995) 1.31
Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord (2000) 1.31
Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis (2000) 1.22
Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol (1996) 1.19
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant (1998) 1.06
Assessment of the current status of iodine prophylaxis in Bosnia and Herzegovina Federation. J Pediatr Endocrinol Metab (2001) 1.06
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol (1994) 1.04
Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol (1993) 0.99
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol (1995) 0.99
Pathologic synovial plica of the knee. Results of conservative treatment. Am J Sports Med (1991) 0.96
Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer (1994) 0.95
Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J Clin Oncol (1991) 0.95
p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res (1998) 0.93
Trauma- and stressor related disorders in the tuareg refugees of a cAMP in burkina faso. Clin Pract Epidemiol Ment Health (2013) 0.91
Endovascular treatment of superior vena cava obstruction in patients with malignancies. Eur Radiol (1999) 0.91
Future development of biologically relevant dosimetry. Br J Radiol (2014) 0.90
SPM nanolithography of hydroxy-silicates. Nanotechnology (2012) 0.90
Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions. Clin Cancer Res (1999) 0.89
p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer (1994) 0.89
Fistulectomy and sphincteric reconstruction for complex cryptoglandular fistulas. Colorectal Dis (2009) 0.88
Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma. Lab Invest (1996) 0.86
A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies. Appl Radiat Isot (2009) 0.85
E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis. Hum Pathol (2004) 0.85
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial. Clin Cancer Res (1999) 0.85
Neuroendocrine phenotype in lung cancers. Comparison of immunohistochemistry with biochemical determination of enolase isoenzymes. Am J Clin Pathol (1992) 0.84
Feasibility study of a personal dosemeter based upon silicon diodes used in remote controlling. Radiat Prot Dosimetry (2005) 0.84
Microdosimetric investigation at the therapeutic proton beam facility of CATANA. Radiat Prot Dosimetry (2004) 0.82
Thyroid-stimulating hormone and prolactin responses to thyrotropin-releasing hormone in juvenile obesity before and after hypocaloric diet. J Endocrinol Invest (1995) 0.81
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française. Ann Oncol (1997) 0.80
NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas. Hum Pathol (2000) 0.80
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas. Am J Pathol (1997) 0.80
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. Nephron (2001) 0.80
[Atropine poisoning. Importance of the clinical diagnosis]. Minerva Anestesiol (1998) 0.79
[Propofol-ketamine vs propofol-fentanyl in short gynecologic surgery]. Minerva Anestesiol (1990) 0.78
Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma. Eur J Cancer (1994) 0.78
Towards the final BSA modeling for the accelerator-driven BNCT facility at INFN LNL. Appl Radiat Isot (2011) 0.78
Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med (1997) 0.78
Determination of selenium in blood serum by proton-induced X-ray emission. Anal Chem (1977) 0.77
Neonatal erythrocyte glutathione peroxidase deficiency as a consequence of selenium imbalance during pregnancy. Br J Haematol (1979) 0.77
Integration of peritoneal dialysis and transplantation programs. Perit Dial Int (1997) 0.77
[The effect of GH on erythropoiesis in vivo]. Minerva Endocrinol (1993) 0.77
[Respiratory infection and bronchial cancer]. Rev Mal Respir (1992) 0.77
Be target development for the accelerator-based SPES-BNCT facility at INFN Legnaro. Appl Radiat Isot (2009) 0.77
BNCT dosimetry performed with a mini twin tissue-equivalent proportional counters (TEPC). Appl Radiat Isot (2009) 0.76
[Knemometry in the assessment of short term effects of growth hormone therapy in children with several growth disorders]. Minerva Pediatr (1997) 0.76
Cyanines as efficient photosensitizers in photodynamic reaction: photophysical properties and in vitro photodynamic activity. Biochemistry (Mosc) (2011) 0.76
Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome. Clin Endocrinol (Oxf) (1998) 0.76
Study of a solid state microdosemeter based on a monolithic silicon telescope: irradiations with low-energy neutrons and direct comparison with a cylindrical TEPC. Radiat Prot Dosimetry (2010) 0.76
Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia. Eur Arch Psychiatry Neurol Sci (1989) 0.75
[Relationship between blood insulin and arterial hypertension in obese adults]. Minerva Med (1991) 0.75
Microdosimetric assessment of the radiation quality of a therapeutic proton beam: comparison between numerical simulation and experimental measurements. Radiat Prot Dosimetry (2010) 0.75
Dexfentluramine in the treatment of juvenile obesity. Minerva Pediatr (1997) 0.75
Analysis of the CONRAD computational problems expressing only stochastic uncertainties: neutrons and protons. Radiat Prot Dosimetry (2008) 0.75
[Percutaneous treatment of superior vena cava obstruction]. Rev Mal Respir (1999) 0.75
Track nanodosimetry of 20-MeV protons at 20 nm. Radiat Prot Dosimetry (2010) 0.75
Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine. Int J Radiat Oncol Biol Phys (1998) 0.75
[The TRH test in Turner syndrome]. Minerva Endocrinol (1993) 0.75
Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients. AJR Am J Roentgenol (1995) 0.75
A feasibility study of a solid-state microdosimeter. Appl Radiat Isot (2005) 0.75
The STARTRACK experiment. Radiat Prot Dosimetry (2007) 0.75
Bronchorrhea revealing cervix adenocarcinoma metastastic to the lung. Lung Cancer (2001) 0.75
Charge collection imaging of a monolithic DeltaE-E telescope for radiation protection applications. Radiat Prot Dosimetry (2007) 0.75
[Cavitary images and dysphonia in a young woman]. Rev Pneumol Clin (1995) 0.75
[Respective roles of the products of the mdr1 and p53 genes in drug resistance of bronchial cancers]. Bull Cancer (1994) 0.75
Neutron spectrometry with a monolithic silicon telescope. Radiat Prot Dosimetry (2007) 0.75
[How can the extension of lung cancer to the osteo-muscular wall of the diaphragm, the pleura and the apex be assessed radiologically?]. Rev Mal Respir (1992) 0.75
Effect of a 3-week body mass reduction program on body composition, muscle function and motor performance in pubertal obese boys and girls. J Endocrinol Invest (2004) 0.75
Secondary photon fields produced in accelerator-based sources for neutron generation. Radiat Prot Dosimetry (2005) 0.75
Melatonin response to TRH in prepubertal and pubertal healthy subjects. Horm Metab Res (1993) 0.75
A case of tropical pulmonary eosinophilia. Clin Infect Dis (1994) 0.75
[Scientific work management and positive personal conduct]. Osterr Schwesternztg (1967) 0.75
Long-term outcomes of peritoneal dialysis. Perit Dial Int (1997) 0.75
Combination of 5-FU cisplatinum and hypofractionated irradiation followed by split-course radiotherapy in 47 patients with unresectable non small cell lung cancer. Radiother Oncol (1992) 0.75
[Scientific work management and positive personal conduct]. Osterr Schwesternztg (1967) 0.75
Long-term peritoneal dialysis outcome in a single center. Perit Dial Int (2000) 0.75
[Cushing syndrome and small cell carcinoma. Three case reports]. Rev Mal Respir (1997) 0.75
A recoil-proton spectrometer based on a p-i-n diode implementing pulse-shape discrimination. Radiat Prot Dosimetry (2004) 0.75
[Iodine deficiency in the Federation of Bosnia and Herzegovina]. Med Arh (2000) 0.75
Controlled positive and negative surface charge injection and erasure in a GaAs/AlGaAs based microdevice by scanning probe microscopy. Nanotechnology (2008) 0.75
Note: radiofrequency scanning probe microscopy using vertically oriented cantilevers. Rev Sci Instrum (2012) 0.75
[Social integration in adulthood in a group of subjects with Turner syndrome]. Minerva Pediatr (1993) 0.75
[Epidemiology of childhood obesity: prevalence in North-West Italy]. Minerva Pediatr (1996) 0.75
Performance of a neutron spectrometer based on a PIN diode. Radiat Prot Dosimetry (2005) 0.75
[Effect of sex on the increase of GH induced by galanin, alone or in combination with GHRH with or without pyridostigmine in pubescent subjects]. Minerva Endocrinol (1996) 0.75
An ongoing randomized study of neoadjuvant chemotherapy in resectable non-small cell lung cancer. Semin Oncol (1994) 0.75